Circulating Fibrocytes: Cellular Mediators of Tissue Fibrosis.

Area of Science:

• Pathology
• Immunology
• Regenerative Medicine

Background:

• Fibrosis is a detrimental excessive tissue repair response affecting multiple organs and posing a global health challenge.
• Current antifibrotic therapies have limited efficacy due to the complexity of fibrotic mechanisms and effector cells.
• Advancements in omics and machine learning enhance understanding of cellular roles in fibrosis.

Purpose of the Study:

• To review the characteristics and roles of circulating fibrocytes in fibrosis.
• To explore mechanisms of fibrocyte recruitment and differentiation.
• To identify fibrocytes as potential therapeutic targets for antifibrotic strategies.

Main Methods:

• Literature review of recent studies on fibrosis and fibrocytes.
• Analysis of high-throughput omics data and machine learning applications.
• Synthesis of information on fibrocyte biology and pathology.

Main Results:

• Circulating fibrocytes, derived from bone marrow, are recruited to injury sites.
• Fibrocytes contribute to fibrosis in various parenchymal and non-parenchymal tissues.
• These cells play roles in inflammation, tissue repair, and fibrosis progression.

Conclusions:

• Circulating fibrocytes are significant contributors to fibrosis across diverse tissues.
• Understanding fibrocyte recruitment and differentiation is crucial for fibrosis research.
• Fibrocytes represent a promising target for developing novel antifibrotic therapies.